Effects of a Water, Sanitation and Hygiene Mobile Health Program on Respiratory Illness in Bangladesh: A Cluster-Randomized Controlled Trial of the CHoBI7 Mobile Health Program.


Journal

The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507

Informations de publication

Date de publication:
10 01 2022
Historique:
received: 15 06 2021
accepted: 06 10 2021
pubmed: 11 1 2022
medline: 26 4 2022
entrez: 10 1 2022
Statut: epublish

Résumé

Acute respiratory infections are a leading cause of morbidity and mortality among young children globally. The objective of this study was to evaluate the impact of the Cholera-Hospital-Based-Intervention-for-7-days (CHoBI7) handwashing with soap and water treatment mobile health (mHealth) program on respiratory illness among diarrhea patients and their household members in urban Dhaka, Bangladesh. A cluster-randomized controlled trial of the CHoBI7 mHealth program was conducted among diarrhea patient households in Dhaka, Bangladesh. Patients were randomized to three arms: standard recommendation on oral rehydration solution use, health facility delivery of CHoBI7 plus mHealth (weekly voice and text messages for 12 months) (no home visits), and health facility delivery of CHoBI7 plus two home visits and mHealth. Respiratory symptoms were assessed during monthly clinical surveillance over the 12-month surveillance period. Respiratory illness was defined as rapid breathing, difficulty breathing, wheezing, or coughing. Two thousand six hundred twenty-six participants in 769 households were randomly allocated to three arms: 849 participants to the standard message arm, 886 to the mHealth with no home visits arm, and 891 to the mHealth with two home visits arm. Compared with the standard message arm, participants in the mHealth with no home visits arm (Prevalence Ratio [PR]: 0.89 [95% CI: 0.80, 0.98]), and the mHealth with two home visits arm (PR: 0.89 [95% CI: 0.81, 0.99]) had significantly lower respiratory illness prevalence over the 12-month program period. Our findings demonstrate that the CHoBI7 mHealth program is effective in reducing respiratory illness among diarrhea patient households.

Identifiants

pubmed: 35008045
doi: 10.4269/ajtmh.21-0679
pmc: PMC8922503
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

979-984

Références

BMC Public Health. 2010 Sep 09;10:545
pubmed: 20828412
Lancet. 2005 Jul 16-22;366(9481):225-33
pubmed: 16023513
Influenza Other Respir Viruses. 2013 Sep;7(5):738-49
pubmed: 23043518
Am J Trop Med Hyg. 2012 Oct;87(4):594-601
pubmed: 22869631
J Glob Health. 2019 Dec;9(2):020402
pubmed: 31360445
BMC Public Health. 2019 Jul 31;19(1):1028
pubmed: 31366398
Heliyon. 2018 Oct 04;4(10):e00841
pubmed: 30302413
Am J Public Health. 2008 Aug;98(8):1372-81
pubmed: 18556606
Trop Med Int Health. 2018 Aug;23(8):816-833
pubmed: 29799658
J Allergy Clin Immunol. 2015 Mar;135(3):616-25
pubmed: 25282018
Cochrane Database Syst Rev. 2021 Jan 6;12:CD004265
pubmed: 33539552
Lancet Infect Dis. 2018 Nov;18(11):1191-1210
pubmed: 30243584
Am J Trop Med Hyg. 2020 Jun;102(6):1286-1295
pubmed: 32228789
Croat Med J. 2013 Apr;54(2):110-21
pubmed: 23630139
Am J Trop Med Hyg. 2013 Sep;89(3):411-8
pubmed: 23836575
J Glob Health. 2020 Dec;10(2):020438
pubmed: 33437462
J Health Commun. 2014;19 Suppl 1:164-89
pubmed: 25207452
Am J Trop Med Hyg. 2020 May;102(5):1124-1130
pubmed: 32100681
PLoS One. 2015 Jan 30;10(1):e0116380
pubmed: 25635911
PLoS Negl Trop Dis. 2018 Jul 27;12(7):e0006641
pubmed: 30052631
Am J Trop Med Hyg. 2016 Feb;94(2):428-36
pubmed: 26728766
BMC Public Health. 2020 Jun 1;20(1):831
pubmed: 32487209
Emerg Infect Dis. 2015 Nov;21(11):2006-13
pubmed: 26484778
PLoS Med. 2013;10(1):e1001362
pubmed: 23349621
Clin Infect Dis. 2021 Nov 2;73(9):e2560-e2568
pubmed: 32761174
Am J Trop Med Hyg. 2014 Aug;91(2):415-23
pubmed: 24914003
Emerg Infect Dis. 2016 Feb;22(2):233-41
pubmed: 26811968
Am J Trop Med Hyg. 2016 Jun 1;94(6):1418-25
pubmed: 27114292

Auteurs

Christine Marie George (CM)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

Jamie Perin (J)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

Tahmina Parvin (T)

International Centre for Diarrhoeal Disease Research, Bangladesh.

Sazzadul Bhuyian (S)

International Centre for Diarrhoeal Disease Research, Bangladesh.

Elizabeth D Thomas (ED)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

Shirajum Monira (S)

International Centre for Diarrhoeal Disease Research, Bangladesh.

Fatema Zohura (F)

International Centre for Diarrhoeal Disease Research, Bangladesh.

Tasdik Hasan (T)

International Centre for Diarrhoeal Disease Research, Bangladesh.

David Sack (D)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

Munirul Alam (M)

International Centre for Diarrhoeal Disease Research, Bangladesh.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH